Drugs / gp160 Vaccine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000745 | ? → May 1991 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00001026 | ? → Dec 1994 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp160 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000745 ↗ |
| Modality | Vaccine | “gp160 vaccine (40 mcg)” NCT00000745 ↗ |